Peter Lobie obtained a B.Med.Sci. (Distinction) and M.B.,B.S, (Medicine and Surgery, First Class Honours) in 1992 from the University of Queensland in Australia. He was awarded the highest accolade from the University in the form of a University Medal. His postdoctoral work was undertaken at the Karolinska Institute in Sweden where he also obtained his doctoral degree (PhD). He has consecutively held faculty positions in Sweden, Singapore and New Zealand. He was also New Zealands first chair of Breast Cancer funded by the Breast Cancer Research Trust. He also is author of over 170 publications and is an international authority on molecular mechanisms of hormone action with more than 7400 citations and a h-factor of 53. Recent emphasis in his laboratory has focused on the capacity of specific secreted proteins to initiate or progress cancer and thereby evaluation of individual molecules for their potential therapeutic application.
Vijay Kumar Pandey
Education:
2006.9-2010.3, Ph.D., Molecular Medicine, University of Auckland, New Zealand (NZ). Thesis title: ‘Secreted oncogenes in human endometrial carcinoma’.
2000.6-2003.5, M.Sc., Microbiology, University of Pune, India.
Dissertation title: ‘Enhancement, optimization and purification of b-galactosidase from Aureobasidium pullulans’.
1996.6-1999.5, B.Sc., Microbiology, Sardar Patel University, India
Awards & Scholarship:
2009 Postdoctoral Fellowship, Dept. of Human & Molecular Genetics, VCU, USA
2009 Travel Award, 21st Lorne Cancer Conference, Lorne, Australia
2007, 2008, 2009 Travel Award, National Research Centre for Growth and Development (NRCGD), NZ
2006 International Doctoral Scholarship, NRCGD, NZ
职位描述:
A postdoctoral position is available immediately for highly motivated Ph.D. graduates with background in oncology, molecular or cellular biology, biochemistry or other related fields who are interested in deciphering functions and targeting of oncogenic proteins in the context of cancer. The laboratory has developed a number of patented and novel drugs to novel therapeutic targets in oncology and the preclinical development and characterization of these drugs in various clinical contexts will form the basis for the programme. The successful candidate will help to design experiments, conduct experiments, analyse data, write papers, write grants, mentor students, and compete for fellowships.
任职要求:
1) A Ph.D. in cancer biology or related area, the doctoral degree obtained within 2 years;
2) Be under the age of 35 and physically adequate;
3) Expertise in DNA and protein biology (including work on oncogenic proteins and transcription factors) is preferred;
4) Strong background and working knowledge of basic molecular and cellular biology techniques such as cell culture, cloning, real-time PCR and western blotting;
5) Any experience with animal modelling, analyses of human clinical samples, is highly desirable;
6) Experience in drug development, mechanisms and interactions;
7) A proven track record in the form of publications in international English language journals;
8) Ability to communicate in written and spoken English.
应聘材料:
Applications should include full curriculum vitae, publication list, and names and contact information of 3 referees. Please also include a summary of your research experience and a brief paragraph on why you want to join the Lobie lab.